Form 8-K · Current report
Illinois Tool Works 8-K, filed Aug 13, 2026
- Filed
- CIK
- 0000049826
- Accession no.
- 0001193125-26-349149
Summary
On August 13, 2026, Illinois Tool Works issued $1.5 billion of 4.650% notes due 2029 under an underwriting agreement with Citigroup Global Markets Inc. and J.P. Morgan Securities LLC as representatives, and it intends to use the net proceeds to repay a portion of its commercial paper indebtedness.
Key points
- The notes mature on August 13, 2029, and pay 4.650% interest annually in semi-annual installments beginning February 13, 2027.
- The underwriting agreement was dated August 11, 2026, with Citigroup Global Markets Inc. and J.P. Morgan Securities LLC acting as representatives of the underwriters.
- Illinois Tool Works intends to use remaining proceeds for general corporate purposes, which may include repaying other outstanding indebtedness.
- The notes were issued under the company’s shelf registration statement and an indenture with The Bank of New York Mellon Trust Company, N.A. as successor trustee.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On August 11, 2026, Illinois Tool Works Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) among the Company and the several underwriters named therein (collectively, the “Underwriters”), for which Citigroup Global Markets Inc. and J.P. Morgan Securities LLC acted as representatives. A copy of the Underwriting Agreement is filed herewith as Exhibit 1.1 and is incorporated by reference herein. On August 13, 2026, the Company issued $1.5 billion in aggregate principal amount of 4.650% notes due 2029 (the “Notes”), pursuant to the Company’s shelf registration statement on Form S-3 ASR (Registration No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.